Stocks making the biggest moves premarket: Eli Lilly, Cigna, Restaurant Brands and more

Stocks making the biggest moves premarket: Eli Lilly, Cigna, Restaurant Brands and more


Take a look at some of the biggest movers in the premarket:

Eli Lilly (LLY) – The drug maker’s stock fell 3.6% in the premarket after it missed estimates with its quarterly results and cut its full-year forecast. Lilly’s performance during the quarter was impacted by lower prices for insulin and falling sales of its Covid-19 treatment.

Cigna (CI) – The insurance company reported better-than-expected profit and revenue for the second quarter and raised its full-year outlook. Cigna was helped by lower costs resulting from a slow rebound in non-urgent medical procedures. Cigna rose 2.6% in premarket trading.

Restaurant Brands (QSR) – The parent of Popeyes, Tim Hortons and Burger King beat top- and bottom-line estimates for its latest quarter, with comparable restaurant sales also rising more than expected. Restaurant Brands added 1.8% in premarket action.

Alibaba (BABA) – Shares of the China-based e-commerce giant jumped 5.2% in premarket trading after better-than-expected quarterly results. That came despite flat revenue growth for the first time ever, due to Covid-19-related lockdowns in China.

Paramount Global (PARA) – Paramount fell 4% in the premarket despite better-than-expected quarterly results, which got a boost from the success of “Top Gun: Maverick.” Paramount did note that it spent more on its direct-to-consumer services during the quarter, with its flagship Paramount+ streaming service gaining 4.9 million subscribers.

Shake Shack (SHAK) – The restaurant chain’s shares slid 5.7% in the premarket despite avoiding an expected loss with a breakeven quarter on an adjusted basis. Shake Shake’s revenue missed Wall Street forecast, and the company said June sales were below its expectations after April and May sales came in as expected.

Booking Holdings (BKNG) – The parent of Priceline and other travel services reported better-than-expected quarterly profit, but revenue missed forecasts and the company said travel difficulties like flight cancellations cut into its July growth. Booking Holdings fell 3.1% in the premarket.

Clorox (CLX) – Clorox shares slid 5.9% in premarket trading as higher costs offset price hikes for the company’s consumer products in its latest quarter. Revenue fell slightly below estimates, though earnings did match Wall Street forecasts.

Toyota Motor (TM) – The automaker’s shares fell 3.5% in premarket action after it reported a 42% drop in profit from a year ago for its latest quarter. Toyota was impacted by supply chain issues and rising costs, which prevented it from producing as many cars as it had intended.



Source

Coinbase joining S&P 500 days after bitcoin soared past 0,000
Finance

Coinbase joining S&P 500 days after bitcoin soared past $100,000

Key Points Coinbase is joining the S&P 500, replacing Discover Financial, which is being acquired. Shares of the crypto exchange soared in extended trading after the announcement. Bitcoin eclipsed the $100,000 market last week, approaching its record reached in January. Source

Read More
After UK and China trade deals, tariff rate still highest since 1934, Yale report says
Finance

After UK and China trade deals, tariff rate still highest since 1934, Yale report says

Key Points The average effective tariff rate on imports is 17.8%, the highest since 1934, even after trade deals reached with China and the U.K. in recent days, according to the Yale Budget Lab. Levies that President Trump placed on other products and countries still remain, including a 10% tariff on almost all trading partners. […]

Read More
Stocks making the biggest moves midday: Amazon, Alibaba, Merck, Five Below, Nike and more
Finance

Stocks making the biggest moves midday: Amazon, Alibaba, Merck, Five Below, Nike and more

Check out the companies making headlines in midday trading: Drugmakers — Pharmaceutical stocks bounced back from earlier losses after an executive order aimed at bringing down drug prices was deemed not as bad as feared for the industry. Merck jumped 5%, while Pfizer , Bristol-Myers Squibb and Eli Lilly all rose more than 2%. However, […]

Read More